Clinical activity and safety of cobimetinib (cobi) and atezolizumab in colorectal cancer (CRC).

Author:

Bendell Johanna C.1,Kim Tae Won2,Goh Boon C.3,Wallin Jeffrey4,Oh Do-Youn5,Han Sae-Won6,Lee Carrie B.7,Hellmann Matthew David8,Desai Jayesh9,Lewin Jeremy Howard10,Solomon Benjamin J.11,Chow Laura Quan Man12,Miller Wilson H.13,Gainor Justin F.14,Flaherty Keith15,Infante Jeffrey R.1,Das-Thakur Meghna4,Foster Paul4,Cha Edward4,Bang Yung-Jue5

Affiliation:

1. Sarah Cannon Research Institute, Nashville, TN;

2. Asan Medical Center, Seoul, South Korea;

3. National University Cancer Institute, National University Health System, Singapore, Singapore, Singapore;

4. Genentech, Inc., South San Francisco, CA;

5. Seoul National University Hospital, Seoul, Korea, The Republic of;

6. Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea;

7. The Univ of North Carolina, Chapel Hill, NC;

8. Memorial Sloan Kettering Cancer Center, New York, NY;

9. Royal Melbourne Hospital, Melbourne, Australia;

10. Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada;

11. Peter MacCallum Cancer Centre, Melbourne, Australia;

12. University of Washington, Seattle, WA;

13. Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada;

14. Massachusetts General Hospital, Boston, MA;

15. Massachusetts General Hospital and Dana-Farber Cancer Institute, Boston, MA;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3